Early development of metabolic syndrome in patients subjected to lung transplantation

Gabriele Savioli, Sara Surbone, Ilaria Giovi, Francesco Salinaro, Paola Preti, Federica Meloni, Tiberio Oggionni, Stefano Perlini

Research output: Contribution to journalArticlepeer-review


Cardiovascular disease is a common cause of morbidity and mortality after solid organ transplantation, due to a combination of pre-existing cardiovascular risk factors and immunosuppressive drug toxicity. The prevalence of new-onset hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome was assessed after lung transplantation in a cohort of 67 patients (mean age: 48 ± 14 yr). The prevalence of hypertension increased from 19.4% to 70.1% at the three-yr follow-up visit (p 2 (p 

Original languageEnglish
JournalClinical Transplantation
Issue number3
Publication statusPublished - May 2013


  • Cardiovascular risk
  • Diabetes
  • Dyslipidemia
  • Hypertension
  • Immunosuppressive therapy
  • Metabolic syndrome
  • Solid organ transplantation

ASJC Scopus subject areas

  • Transplantation
  • Medicine(all)


Dive into the research topics of 'Early development of metabolic syndrome in patients subjected to lung transplantation'. Together they form a unique fingerprint.

Cite this